2026 Outlook for Pharmacies: PBMs, Regulatory Shifts, Board Enforcement, and DSCSA Readiness

Wed 2/4 from 1-2 pm CST.

Presenters (Buchanan Ingersoll & Rooney PC)

Dae Y. Lee, Pharm.D., Esq.

Lucas Morgan, Esq.

Barbara A. Binzak Blumenfeld, Ph.D., Esq.

Independent pharmacies are heading into 2026 facing intensified pressure from every direction, i.e., PBMs tightening audits and reimbursement, regulators stepping up enforcement, Boards of Pharmacy becoming more aggressive, and DSCSA finally moving from theory to real-world consequences.

In this forward-looking webinar, Dae Y. Lee, Pharm.D., Esq., Lucas Morgan, Esq., and Barbara A. Binzak Blumenfeld, Ph.D., Esq. will break down the most consequential legal, regulatory, and operational developments pharmacies should expect in 2026 and what owners should be doing now to protect their businesses.

This session is designed for pharmacy owners, operators, compliance officers, pharmacists and executives who want straight answers, practical guidance, and a defensible plan for navigating the year ahead.

Learning Objectives

By the end of this webinar, participants will be able to:

1. Identify the most significant PBM enforcement and audit trends expected in 2026 and understand how they impact reimbursement, network participation, and pharmacy survival.
2. Recognize emerging regulatory and manufacturer-driven risks that pharmacies will face beyond traditional payor audits.
3. Understand how PBM disputes increasingly lead to Board of Pharmacy action, and how to mitigate that risk.
4. Assess their pharmacy’s DSCSA readiness and identify operational gaps that could trigger enforcement or supply-chain disruptions.
5. Develop a practical, defensible strategy to prepare for audits, investigations, and compliance challenges in 2026 before problems escalate.

Keep up with the latest APRx and industry news by following us on social media. Click the icons below to be directed to our page.